Glycemic Control and Selected Pregnancy Outcomes in Type 1 Diabetes Women on Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: The Significance of Pregnancy Planning
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Two regimens are used to achieve excellent glycemic control during pregnancy in type 1 diabetes mellitus (T1DM): continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI). We assessed their efficacy and safety and the effect of pregnancy planning. METHODS: We examined 269 pregnant T1DM women: 157 treated with MDI (MDI group), 42 with CSII (CSII group), and 70 who switched from MDI to CSII in the first trimester (MDI/CSII group). There were 116 women who planned pregnancy: 58 in the MDI group, 38 in the CSII group, and 20 in the MDI/CSII group. The estimated differences in glycemic control and maternal and fetal outcomes were adjusted for baseline characteristics. RESULTS: Mean glycated A1c (HbA1c) in the first trimester in the whole group was 6.9%, and the women differed depending on whether they planned pregnancy or not (P < 0.0001). A multiple regression model showed an average difference of about 0.9% in favor of pregnancy planning, with no interaction between the planning and treatments. In the second trimester, HbA1c decreased to a mean value of 5.8%, with improvement of HbA1c across all treatments: by 1.5% in not-planning and 0.9% in planning women. Despite greater improvement, not-planning women still had a higher HbA1c (by 0.3%, P = 0.05). In the third trimester, there was no further significant changes; nevertheless, women who planned pregnancy still had a lower HbA1c (by 0.5%, P = 0.02). There were 14 malformations, stillbirths, and perinatal infant deaths in the not-planning versus five in the planning group (P = 0.07). Patients in the CSII group had a 2 kg greater weight gain compared to the MDI group (15.0 kg vs. 13.0 kg; P = 0.005). CONCLUSIONS: In pregnancy with T1DM, both MDI and CSII can provide excellent glycemic control. Pregnancy planning has a beneficial effect on glycemic control, independent from the therapy model. CSII seems to predispose to a larger weight gain in mothers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outcomes in Type 1 Diabetic Pregnancies
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M., & Beck-Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2819 · Cited by 486 · cited 1×
“9,38 There are a few shortcomings in our study.”
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278 · cited 1×
“33,34 The task of achieving therapeutic goals was generally accomplished in the second and the third tri-mesters in all three groups, CSII, MDI = CSII, and MDI, as indicated by HbA1c level, but it should be pointed out that those levels were still higher than levels observed in pregnant women…”
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes
Plotnick, L. P., Clark, L. M., Brancati, F. L., & Erlinger, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1142 · Cited by 216 · cited 1×
“18,19 20–22 However, data on CSII use in T1DM during pregnancy are scarce.”
Bode, B., Weinstein, R., Bell, D., McGill, J., Nadeau, D., Raskin, P., Davidson, J., Henry, R., Huang, W.-C., & Reinhardt, R. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.439 · Cited by 148 · cited 1×
“14–17 Systematic reviews demonstrated a possible advantage of CSII over MDI in achieving normoglycemia in T1DM.”
Lapolla, A., Dalfr�, M. G., Masin, M., Bruttomesso, D., Piva, I., Crepaldi, C., Tortul, C., Dalla Barba, B., & Fedele, D. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0103-1 · Cited by 67
Cited by
Preconception care for women with diabetes and prevention of major congenital malformations
Kitzmiller, J. L., Wallerstein, R., Correa, A., & Kwan, S. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20734 · Cited by 369
Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237571 · Cited by 130
“…dystocia: (6/265) # Perinatal mortality: (8/265) ~LGA: (75/265) SGA: (20/265) Excessive GWG: (80/265) Neonatal hypoglycemia: (22/ 265) NICU admission: (137/265) 6 Cyganek (2010) Poland [58] PCC: 116 women with (DM-I) NO-PCC: 153 women with (DM-I) PCC included: • Intensive diabetes management.”
Cyganek, K., Skupien, J., Katra, B., Hebda-Szydlo, A., Janas, I., Trznadel-Morawska, I., Witek, P., Kozek, E., & Malecki, M. T. (2017) · Endocrine · doi:10.1007/s12020-016-1134-z · Cited by 94
Self-citationMathiesen, J. M., Secher, A. L., Ringholm, L., Nørgaard, K., Hommel, E., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.837444 · Cited by 58
Metadata
- Authors
- Cyganek, K., Hebda-Szydlo, A., Katra, B., Skupien, J., Klupa, T., Janas, I., Kaim, I., Sieradzki, J., Reron, A., & Malecki, M. T.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2010-01
- Volume
- 12
- Issue
- 1
- Pages
- 41-47
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2153584234
- Cited by
- 65
- References
- 12
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.